COVID-19-CURE

Next up for the COVID-19 vaccine hunt: Testing shots on kids

Oct 21, 2020, 3:47 PM
vaccine kids covid-19 utahns...
In this photo provided by Cincinnati Children’s Hospital Medical Center, clinical research coordinator Tammy Lewis-McCauley administers an injection to Katelyn Evans, a trial participant, as part of the hospital’s clinical trial of Pfizer's COVID-19 vaccine at Cincinnati Children’s Hospital Medical Center on Wednesday, Oct. 14, 2020. (Cincinnati Children’s Hospital Medical Center via AP)
(Cincinnati Children’s Hospital Medical Center via AP)

The global hunt for a COVID-19 vaccine for kids is only just beginning — a lagging start that has some U.S. pediatricians worried they may not know if any shots work for young children in time for the next school year.

Older adults may be most vulnerable to the coronavirus, but ending the pandemic will require vaccinating children, too. Last week, Pfizer Inc. received permission to test its vaccine in U.S. kids as young as 12, one of only a handful of attempts around the world to start exploring if any experimental shots being pushed for adults also can protect children.

“I just figured the more people they have to do tests on, the quicker they can put out a vaccine and people can be safe and healthy,” said 16-year-old Katelyn Evans, who became the first teen to get an injection in the Pfizer study at Cincinnati Children’s Hospital.

Multiple vaccine candidates are in final-stage studies in tens of thousands of adults, and scientists are hopeful that the next few months will bring evidence that at least some of them are safe and effective enough for widespread use.

But when the first shots arrive, they’re unlikely to be recommended for children. Vaccines can’t be given to youngsters unless they’ve been tested in their age group — a major hurdle in efforts to reopen schools and resume more normal activities that are critical to families’ well-being.

“The public doesn’t understand that,” said Dr. Evan Anderson of Emory University, who has been pushing for pediatric testing of COVID-19 vaccines. While he’s encouraged by Pfizer’s study in adolescents, he finds it “very concerning” that children younger than 12 may not have a vaccine by next fall.

Children represent about 10% of COVID-19 cases documented in the U.S. And while children are far less likely than adults to get seriously ill, about 120 have died in the U.S. alone, according to a tally by the American Academy of Pediatrics. That’s about how many U.S. children die from flu in an average year. Additionally, a small number have developed a serious inflammatory condition linked to the coronavirus.

Overall, Anderson says COVID-19’s impact on children is greater than some other diseases that require routine pediatric vaccinations.

Aside from their own health risks is the still unanswered question about how easily children can infect others. In a letter to federal health officials, the AAP cited recent evidence that those over age 10 may spread the virus just as easily as adults do.

Add missing school and other factors unique to children, and it’s unethical “to allow children to take on great burdens during this pandemic but not have the opportunity to benefit from a vaccine,” Dr. Sara Goza, president of the pediatrics academy, wrote.

Globally, pediatric studies are only hesitantly emerging. In China, Sinovac and SinoPharm have opened studies that can test children as young as 3.

A British study of a vaccine by AstraZeneca allows for testing of a low dose in certain children but the company says it won’t be recruiting youngsters until it has “sufficient” safety data in adults.

In the U.S., Moderna Inc., Johnson & Johnson and Novavax all hope to begin some pediatric research later in the year, in varying age groups.

Doing so is critical, said Dr. Robert Frenck, who directs the Vaccine Research Center at Cincinnati Children’s.

“If we immunize adolescents — and potentially move down into younger children — we’re going to have the effect of keeping those children from getting infected. But then also they don’t bring the infection home to parents and grandparents,” he said.

Frenck is finding lots of interest in Pfizer’s adolescent testing, with 90 families seeking more information in just a week after his team issued a call for 16- and 17-year-old volunteers. The researchers plan to enroll 12- to 15-year-olds soon.

Katelyn, the suburban Cincinnati volunteer, doesn’t know if she got a dummy shot or the real vaccine. But the high school junior is excited to be part of the study. And with science class still fresh, she grasped the researchers’ explanation of how Pfizer’s vaccine works — using a piece of genetic code to train the body to recognize if the coronavirus comes along.

“I’ve learned about DNA and RNA and all that stuff in biology in freshman year. And I guess I didn’t really know, like, how it applied to the real world until now,” she said.

It makes sense to start pediatric testing in teenagers and gradually work down in age, Frenck said, because adolescents usually receive adult-sized doses of other vaccines — and so far with Pfizer’s shots, serious safety problems haven’t emerged in adult testing.

Assuming Pfizer’s shot is proven to work in adults, Frenck said the key will be if the vaccine revs up adolescents’ immune systems the same way — without different side effects. He said if all goes well, it’s possible scientists may have an answer about the 12-and-older group by spring.

But younger children need their own testing. Anderson, a pediatric infectious disease specialist at Children’s Healthcare of Atlanta, said those studies may be more complex because smaller tots may need different doses or, because of their typically more robust immune systems, show different reactions to the shots.

“It is quite important for us to begin the process because this will take some time to do the studies the right way,” he said.
___
AP video journalist Kathy Young contributed to this report.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Today’s Top Stories

COVID-19-Cure

FILE - This undated photo provided by Merck & Co. shows their new antiviral medication molnupir...
MATTHEW PERRONE, Associated Press Health Writer

US adds second COVID-19 pill, this time from Merck

U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.
6 months ago
new COVID pills...
MATTHEW PERRONE Associated Press

Pfizer pill becomes 1st US-authorized home COVID treatment

U.S. health regulators authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.
7 months ago
covid pill...
Curt Gresseth

Utah doctor weighs in on new COVID-19 pill you can take at home

A University of Utah doctor specializing in infectious diseases weighs the pros and cons on a new pill taken at home to treat coronavirus.
7 months ago
covid utah...
Paul Nelson

As omicron variant spreads, Utahns urged to get vaccine booster shots

With the spread of the omicron variant, Utahns are being urged to get a COVID-19 vaccine booster shot
7 months ago
COVID vaccination rates...
Heather Kelly

Utah is below the national average for COVID vaccination rates, here’s why

Utah is below the national average for COVID vaccination rates. High numbers of children in Utah are likely skewing the data. Officials encourage vaccination.
7 months ago
utah covid children...
Paul Nelson

Researchers believe ‘omicron’ variant will be in Utah, sooner or later

The Omicron variant doesn't have officials saying we should cancel Christmas plans, but masks and social distancing are still recommended.
7 months ago

Sponsored Articles

Tax Harassment...
Jordan Wilcox

The best strategies for dealing with IRS tax harassment | You have options!

Learn how to deal with IRS tax harassment. This guide will teach you how to stop IRS phone calls and letters, and how to handle an IRS audit.
spend a day at Bear Lake...
Bear Lake Convention and Visitors Bureau

You’ll love spending the day at Bear Lake | How to spend a day at Bear Lake

Bear Lake is a place that needs to be experienced. Spend a day at Bear Lake.
Curb Appeal...
Price's Guaranteed Doors

How to have the best of both worlds for your house | Home security and curb appeal

Protect your home and improve its curb appeal with the latest security solutions like beautiful garage doors and increased security systems.
Prescription opioids can be disposed of during National Prescription Take Back Day...
Know Your Script

Prescription opioid misuse | How to protect your family from the opioid epidemic

Studies have shown that prescription opioid misuse has increased since COVID-19. So what do you need to know about these opioids?
national heart month...
Intermountain Healthcare

National Heart Month: 5 Lifestyle Changes to Make Today to Keep You Heart Healthy

Heart disease is the leading cause of death for both men and women. One person dies every 36 seconds in the United States from cardiovascular disease
Joseph Smith Memorial Building...
Temple Square

The Joseph Smith Memorial Building is an icon of Salt Lake City | Why hosting an event at this beautiful location will make you a hero this year

Here's why hosting an event at the iconic Joseph Smith Memorial Building in downtown Salt Lake City will make you a hero this year.
Next up for the COVID-19 vaccine hunt: Testing shots on kids